SCHEMBL13005674

SCHEMBL13005674

CC(C)Cc1cccc(NC(=O)N[C@@H](CC2CCCCC2)CN(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.46
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
NPY1R P25929 2/20 0.42
ACKR3 P25106 1/20 0.41
EPHX1 P07099 2/20 0.41
EPHX2 P34913 2/20 0.41
F2RL1 P55085 1/20 0.40
NPY5R Q15761 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 1/20 0.38
REN P00797 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PKM P14618 1/20 0.38
ALOX15 P16050 1/20 0.38
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061126 0.86 NPC1 (0.54) EPHX1EPHX2NPC1RAB9A
SCHEMBL13005689 0.83 NPY5R (0.48) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL13005624 0.82 MAPK1 (0.46)
SCHEMBL13005671 0.81 F2 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13005589 0.78 KMT2A (0.41) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL13061130 0.75 MAPT (0.48) SMN1; SMN2NPC1RAB9AALOX15GAA
SCHEMBL13061039 0.72 SMN1; SMN2 (0.52) SMN1; SMN2EPHX2F2RL1NPY5RNPC1
SCHEMBL13256338 0.71 CTSL (0.46) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL13060826 0.71 CTSL (0.44) SMN1; SMN2PSEN1PSEN2APH1BNCSTN
SCHEMBL13005597 0.70 ALDH1A1 (0.42) SMN1; SMN2PSEN1PSEN2APH1BNCSTN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851637-B2 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners INFINITY PHARMACEUTICALS, INC. (US) 2010-12-14 US disclosed